Event dossier

India's cheap weight-loss drugs could reshape global obesity fight

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

0 reports0 sourcesMar 18, 2026, 12:30 AM
FilterEvent feed
Clustered coverageAll sources
Coverage timeline0
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

No linked coverage has been stored for this event yet.
Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.

El Psy Congroo Newswire